The blockbuster GLP-1 drugs that have reshaped the treatment of diabetes and obesity may help prevent multiple substance use disorders — and reduce the tragic outcomes they cause, a large new study ...
Hosted on MSN
GLP‑1 drugs may fight addiction across every major substance, according to a study of 600,000 people
(The Conversation) – A patient of mine, a veteran who had tried to quit smoking for over a decade, told me that after he started a GLP-1 drug for his diabetes, he lost interest in cigarettes. He ...
The government has launched £20m worth of grants for technology to help fight drug and alcohol addiction in the UK. The funding, which will be delivered through Innovate UK, aims to support the ...
Comprehensive addiction training is rare in American medical education, which denies physicians the necessary diagnostic and communication skills required to treat patients with substance use disorder ...
Over six months, more than 60 people receiving medication-assisted treatment for opioid use disorder answered surveys on their smartphones about their mental health, psychological state and ...
Is it just me, or have you noticed the disproportionate number of students who have addictions today? I hear Generation Z students freely acknowledge addictions to pot, vaping, sex, alcohol, and even ...
Did you ever smoke? I did, for a long time (too long). For the first few years, I deluded myself with the idea that I could “stop anytime I wanted,” though never really tested that theory. Then I did ...
As someone with more than 20 years of recovery, I’ve seen what does and does not work when it comes to helping people take back their lives from substance use and move forward. People need safe ...
TOPEKA, Kan. (WIBW) - Kansas is continuing the fight against opioids. The state’s Attorney General’s Office, in partnership with the DCCCA, is presenting its Naloxone Box to schools across Kansas to ...
GLP-1 drugs may fight addiction across every major substance, according to a study of 600,000 people
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Ziyad Al-Aly, Washington University in St. Louis (THE CONVERSATION) A patient of mine, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results